To include your compound in the COVID-19 Resource Center, submit it here.

Amylin, Eli Lilly endocrine news

Amylin alleged Eli Lilly breached the partners' contract for diabetes drug exenatide by making a separate deal with Boehringer Ingelheim GmbH (Ingelheim, Germany) for

Read the full 240 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE